

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in HIV-associated Kaposi sarcoma | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-970/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-970" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in HIV-associated Kaposi sarcoma" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in HIV-associated Kaposi sarcoma.">
            <meta name="og:description" content="Read the latest article version by Alessia Dalla Pria, David J. Pinato, Margherita Bracchi, Mark Bower, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="19029">
            <meta name="article-id" content="17401">
            <meta name="dc.title" content="Recent advances in HIV-associated Kaposi sarcoma">
            <meta name="dc.description" content="Kaposi sarcoma (KS) is a mesenchymal tumour caused by KS-associated herpesvirus and is an AIDS-defining illness. Despite a decline in incidence since the introduction of combination anti-retroviral therapy, KS remains the most common cancer in people living with HIV in sub-Saharan Africa, where it causes significant morbidity and mortality. This review reflects on recent epidemiological data as well as current management, unmet needs and future perspectives in the treatment of HIV-associated KS with particular emphasis on the potential role of immune checkpoint inhibitors.">
            <meta name="dc.subject" content="KS, cART, HIV">
            <meta name="dc.creator" content="Dalla Pria, Alessia">
            <meta name="dc.creator" content="Pinato, David J.">
            <meta name="dc.creator" content="Bracchi, Margherita">
            <meta name="dc.creator" content="Bower, Mark">
            <meta name="dc.date" content="2019/06/26">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.17401.1">
            <meta name="dc.source" content="F1000Research 2019 8:970">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="KS">
            <meta name="prism.keyword" content="cART">
            <meta name="prism.keyword" content="HIV">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/06/26">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="970">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.17401.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-970">
            <meta name="citation_title" content="Recent advances in HIV-associated Kaposi sarcoma">
            <meta name="citation_abstract" content="Kaposi sarcoma (KS) is a mesenchymal tumour caused by KS-associated herpesvirus and is an AIDS-defining illness. Despite a decline in incidence since the introduction of combination anti-retroviral therapy, KS remains the most common cancer in people living with HIV in sub-Saharan Africa, where it causes significant morbidity and mortality. This review reflects on recent epidemiological data as well as current management, unmet needs and future perspectives in the treatment of HIV-associated KS with particular emphasis on the potential role of immune checkpoint inhibitors.">
            <meta name="citation_description" content="Kaposi sarcoma (KS) is a mesenchymal tumour caused by KS-associated herpesvirus and is an AIDS-defining illness. Despite a decline in incidence since the introduction of combination anti-retroviral therapy, KS remains the most common cancer in people living with HIV in sub-Saharan Africa, where it causes significant morbidity and mortality. This review reflects on recent epidemiological data as well as current management, unmet needs and future perspectives in the treatment of HIV-associated KS with particular emphasis on the potential role of immune checkpoint inhibitors.">
            <meta name="citation_keywords" content="KS, cART, HIV">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Alessia Dalla Pria">
            <meta name="citation_author_institution" content="Imperial College London, London, UK">
            <meta name="citation_author_institution" content="Chelsea and Westminster Hospital, London, UK">
            <meta name="citation_author" content="David J. Pinato">
            <meta name="citation_author_institution" content="Imperial College London, London, UK">
            <meta name="citation_author_institution" content="Chelsea and Westminster Hospital, London, UK">
            <meta name="citation_author" content="Margherita Bracchi">
            <meta name="citation_author_institution" content="Chelsea and Westminster Hospital, London, UK">
            <meta name="citation_author" content="Mark Bower">
            <meta name="citation_author_institution" content="Imperial College London, London, UK">
            <meta name="citation_author_institution" content="Chelsea and Westminster Hospital, London, UK">
            <meta name="citation_publication_date" content="2019/06/26">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="970">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.17401.1">
            <meta name="citation_firstpage" content="970">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-970/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-970.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=19029 /> <input type=hidden id=articleId name=articleId value=17401 /> <input type=hidden id=xmlUrl value="/articles/8-970/v1/xml"/> <input type=hidden id=xmlFileName value="-8-970-v1.xml"> <input type=hidden id=article_uuid value=c774e904-58dd-43de-8141-fb24c9942fb2 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in HIV-associated Kaposi sarcoma"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.17401.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.17401.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-970"
  },
  "headline": "Recent advances in HIV-associated Kaposi sarcoma",
  "datePublished": "2019-06-26T10:33:45",
  "dateModified": "2019-06-26T10:33:45",
  "author": [
    {
      "@type": "Person",
      "name": "Alessia Dalla Pria"
    },    {
      "@type": "Person",
      "name": "David J. Pinato"
    },    {
      "@type": "Person",
      "name": "Margherita Bracchi"
    },    {
      "@type": "Person",
      "name": "Mark Bower"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Kaposi sarcoma (KS) is a mesenchymal tumour caused by KS-associated herpesvirus and is an AIDS-defining illness. Despite a decline in incidence since the introduction of combination anti-retroviral therapy, KS remains the most common cancer in people living with HIV in sub-Saharan Africa, where it causes significant morbidity and mortality. This review reflects on recent epidemiological data as well as current management, unmet needs and future perspectives in the treatment of HIV-associated KS with particular emphasis on the potential role of immune checkpoint inhibitors."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-970/v1",
            "name": "Recent advances in HIV-associated Kaposi sarcoma"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in HIV-associated Kaposi sarcoma </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=19029 data-id=17401 data-downloads="" data-views="" data-scholar="10.12688/f1000research.17401.1" data-recommended="" data-doi="10.12688/f1000research.17401.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-970/v1/pdf?article_uuid=c774e904-58dd-43de-8141-fb24c9942fb2" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-17401-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-17401-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-17401-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Dalla Pria A, Pinato DJ, Bracchi M and Bower M. Recent advances in HIV-associated Kaposi sarcoma [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):970 (<a class=new-orange href="https://doi.org/10.12688/f1000research.17401.1" target=_blank>https://doi.org/10.12688/f1000research.17401.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-17401-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=17401 id=track-article-signin-17401 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/17401?target=/articles/8-970/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=19029 /> <input name=articleId type=hidden value=17401 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in HIV-associated Kaposi sarcoma</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:a.dalla-pria17@imperial.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Alessia Dalla Pria</span></a><a href="https://orcid.org/0000-0002-7421-6002" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-7421-6002</div><sup>1,2</sup>,&nbsp;</span><span class="">David J. Pinato<sup>1,2</sup>,&nbsp;</span><span class="">Margherita Bracchi<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:m.bower@imperial.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Mark Bower</span></a><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:a.dalla-pria17@imperial.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Alessia Dalla Pria</span></a><a href="http://orcid.org/0000-0002-7421-6002" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-7421-6002</div><sup>1,2</sup>,&nbsp;</span><span class="">David J. Pinato<sup>1,2</sup>,&nbsp;</span><span class="">Margherita Bracchi<sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:m.bower@imperial.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Mark Bower</span></a><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 26 Jun 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.17401.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Imperial College London, London, UK<br/> <sup>2</sup> Chelsea and Westminster Hospital, London, UK<br/> <p> <div class=margin-bottom> Alessia Dalla Pria <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> David J. Pinato <br/> <span>Roles: </span> Conceptualization, Data Curation, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Margherita Bracchi <br/> <span>Roles: </span> Conceptualization, Data Curation, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Mark Bower <br/> <span>Roles: </span> Conceptualization, Data Curation, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=52339-49662></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=35937-49663></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Kaposi sarcoma (KS) is a mesenchymal tumour caused by KS-associated herpesvirus and is an AIDS-defining illness. Despite a decline in incidence since the introduction of combination anti-retroviral therapy, KS remains the most common cancer in people living with HIV in sub-Saharan Africa, where it causes significant morbidity and mortality. This review reflects on recent epidemiological data as well as current management, unmet needs and future perspectives in the treatment of HIV-associated KS with particular emphasis on the potential role of immune checkpoint inhibitors. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> KS, cART, HIV </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Alessia Dalla Pria (<a href="mailto:a.dalla-pria17@imperial.ac.uk">a.dalla-pria17@imperial.ac.uk</a>) <br> Mark Bower (<a href="mailto:m.bower@imperial.ac.uk">m.bower@imperial.ac.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding authors:</b> Alessia Dalla Pria, Mark Bower </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2019 Dalla Pria A <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Dalla Pria A, Pinato DJ, Bracchi M and Bower M. Recent advances in HIV-associated Kaposi sarcoma [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):970 (<a href="https://doi.org/10.12688/f1000research.17401.1" target=_blank>https://doi.org/10.12688/f1000research.17401.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 26 Jun 2019, <b>8</b>(F1000 Faculty Rev):970 (<a href="https://doi.org/10.12688/f1000research.17401.1" target=_blank>https://doi.org/10.12688/f1000research.17401.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 26 Jun 2019, <b>8</b>(F1000 Faculty Rev):970 (<a href="https://doi.org/10.12688/f1000research.17401.1" target=_blank>https://doi.org/10.12688/f1000research.17401.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d34136e194>Introduction and context</h2><p class="" id=d34136e197>Kaposi sarcoma (KS) is an angio-proliferative disorder that was first described in its classic form by the Hungarian physician Moritz Kaposi in 1872. It is categorised in different disease types that are all aetiologically associated with KS-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8). The malignant cell of KS is the spindle cell which is infected by KSHV and is believed to be of lymphatic endothelial origin. KS lesions are composed of a combination of abnormal vascularity, inflammation and fibrosis with hemosiderin deposits.</p><p class="" id=d34136e200>There are four widely recognised epidemiological forms of KS: classic KS, which is a relatively indolent disease that mainly affects elderly men from the Mediterranean basin and Middle East; African (endemic) KS, which pre-existed the HIV/AIDS pandemic<sup><a href="#ref-1">1</a></sup>; allograft transplantation-associated (iatrogenic) KS; and AIDS-associated (epidemic) KS, which is characterised by potentially aggressive clinical features.</p><p class="" id=d34136e207>Despite being a relatively infrequent malignancy worldwide, KS remains the most common cancer in people living with HIV (PLWH) in the African continent and is one of the most common tumours, especially in children in central, eastern and southern Africa<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>. WHO-GLOBOCAN data indicate that there were 41,799 new KS diagnoses (28,248 males and 13,551 females) and 19,902 (13,117 males and 6,785 females) KS deaths globally in 2018<sup><a href="#ref-4">4</a></sup>.</p><p class="" id=d34136e221>The introduction of combination anti-retroviral therapy (cART) led to a remarkable decline in AIDS-KS incidence<sup><a href="#ref-5">5</a></sup> and to a significant improvement in KS prognosis<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. However, KS still accounts for significant morbidity and mortality, particularly in sub-Saharan countries. Although the incidence of KS fell with the cART-induced rise in CD4 T-cell count and immune reconstitution, the risk of developing KS in PLWH with a normal CD4 T-cell count remains substantially higher than in the general population<sup><a href="#ref-8">8</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d34136e242>Management of HIV-KS</h2><p class="" id=d34136e245>A conspicuous body of clinical evidence indicates that AIDS-KS can regress following starting cART alone<sup><a href="#ref-9">9</a>,<a href="#ref-10">10</a></sup>, suggesting a proportion of cases to be fully sensitive to cART-mediated immune reconstitution. After starting cART, patients with anti-retroviral–naïve HIV recover their immunity, at least in part, within months. Responses to cART alone are variable. Complete remission of KS occurs in 20 to 80% of patients and is more frequent in cART-naïve patients with limited-stage disease who are compliant with HIV therapy<sup><a href="#ref-11">11</a></sup>. The mechanism of KS regression is thought to be immunological and specifically associated with reconstitution of an effective cytotoxic cell–mediated response targeting KSHV. As KS can rapidly progress and affect vital organs, patients with advanced-stage KS (<a href="#T1">Table 1</a>) need additional systemic anti-cancer treatment alongside cART<sup><a href="#ref-12">12</a></sup>. Additionally, a proportion of HIV-infected patients will develop KS <i>de novo</i> or will experience disease progression after starting cART and this phenomenon may be an indicator of unmasking and paradoxical immune reconstitution inflammatory syndrome. There are no controlled trials to evaluate the best care of such patients, although systemic chemotherapy for KS, and not steroid treatment that is associated with disease progression, seems appropriate as reported in small series and case reports<sup><a href="#ref-13">13</a>–<a href="#ref-16">16</a></sup>.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Kaposi sarcoma staging.</h3></div><table xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d34136e288 class=n-a></a><thead><a name=d34136e290 class=n-a></a><tr><a name=d34136e292 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d34136e294 class=n-a></a>Kaposi<br class=br>sarcoma<br class=br>staging</th><th align=left colspan=1 rowspan=1 valign=top><a name=d34136e301 class=n-a></a>Early stage/good risk<br class=br>(all of the<br class=br>following)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d34136e308 class=n-a></a>Advanced stage/poor<br class=br>risk (any of<br class=br>the following)</th></tr></thead><tbody><a name=d34136e317 class=n-a></a><tr><a name=d34136e319 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d34136e321 class=n-a></a>T (tumour)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d34136e324 class=n-a></a>T0:<br class=br>Confined to skin,<br class=br>lymph nodes or<br class=br>minimal oral disease</td><td align=left colspan=1 rowspan=1 valign=top><a name=d34136e333 class=n-a></a>T1:<br class=br>Tumour-associated<br class=br>oedema<br class=br>Ulceration<br class=br>Extensive oral disease<br class=br>Visceral disease (non-<br class=br>nodal)</td></tr><tr><a name=d34136e350 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d34136e352 class=n-a></a>I (immune<br class=br>status)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d34136e357 class=n-a></a>I0:<br class=br>CD4 &gt;150/mL</td><td align=left colspan=1 rowspan=1 valign=top><a name=d34136e362 class=n-a></a>I1:<br class=br>CD4 &lt;150/mL</td></tr></tbody></table></div><p class="" id=d34136e371>Prior to the advent of cART, a number of agents, including interferon-alpha, thalidomide, retinoids and cytotoxics such as vincristine and bleomycin, were used in the treatment of HIV-KS. However, the advent of liposomal anthracyclines in the early 1990s is recognised as a significant advancement in the chemotherapy of KS and has become the gold standard of care. Their role has been consolidated by level-I evidence from three randomised controlled trials that showed better response rates and favourable toxicity profiles<sup><a href="#ref-17">17</a>,<a href="#ref-18">18</a></sup> compared with previous standard chemotherapy of bleomycin and vincristine with or without Adriamycin (doxorubicin). Treatment responses were often non-sustained in these initial trials that predated the introduction of cART. In advanced-stage KS, the concomitant use of cART and liposomal anthracyclines achieves a 70% overall response rate with prolonged remission<sup><a href="#ref-19">19</a></sup>. Over time, improvements in the understanding of kinetics of immune reconstitution and the consolidating knowledge that cART is an effective and sufficient therapy for people with early stage KS (T0)<sup><a href="#ref-20">20</a></sup>, but not for patients with advanced disease (T1 stage), led to the consolidation of a stage-stratified approach in patients with KS. This approach, proposed in the British HIV Association guidelines for HIV malignancies (BHIVA)<sup><a href="#ref-21">21</a></sup>, supports the use of cART alone for early-stage KS (T0), reserving the addition of liposomal anthracycline chemotherapy for more aggressive disease (T1), based on evidence of efficacy in PLWH with visceral KS. The effectiveness of a stage-stratified approach to KS was further consolidated by a landmark study that described a cohort of 469 patients, confirming that this approach achieves high survival rates in patients with advanced KS (5-year overall survival [OS] 85%) and reduces exposure to chemotherapy in patients with early-stage disease (5-year OS 95%)<sup><a href="#ref-22">22</a></sup>.</p><p class="" id=d34136e397>Even with the notable advancements in the systemic management of KS, up to 15% of patients develop progressive disease despite achieving good immune-virologic control of HIV with undetectable plasma HIV-1 RNA and adequate CD4 T-cell counts (&gt;300/mm<sup>3</sup>)<sup><a href="#ref-23">23</a>–<a href="#ref-25">25</a></sup>. The immunopathology of cART-refractory KS is complex. Mechanistic studies have recognised that this type of disease is associated with T cell–immune senescence as a key pathophysiologic trait and that in some patients it has an indolent clinical course similar to that of the classic subtype<sup><a href="#ref-24">24</a>,<a href="#ref-26">26</a></sup>. In our HIV-cancer centre, this group of patients usually receives multiple cycles of chemotherapy alternating between liposomal anthracycline and paclitaxel. Sequential alternation of non–cross-reacting chemotherapy agents has been found to be an effective approach to control HIV-KS in a series of 20 patients however, no comparative studies are available and this treatment strategy may lead to increased chemotherapy toxicities<sup><a href="#ref-27">27</a></sup>. Cardiotoxicity is linked to cumulative dosage of anthracyclines<sup><a href="#ref-28">28</a></sup>, although the risk is lower with the liposomal formulation and high cumulative dosages of taxanes, used as a second-line therapy, are associated with irreversible peripheral neuropathy<sup><a href="#ref-29">29</a></sup>.</p><p class="" id=d34136e431>Local treatments, such as surgical excision, intralesional vinblastine and radiotherapy, are rarely used as they do not have an impact on the natural history of the systemic disease and specifically radiation therapy can be associated with long-lasting local toxicity. They can be used to control non-rapidly progressive cutaneous lesions where cART alone has not achieved a good result. Intralesional vinblastine is administered for lesions that are smaller than 1 cm whereas radiotherapy may be used for bigger lesions (&gt;1 cm).</p><p class="" id=d34136e434>Although recent efforts have made cART available in most resource-limited settings, access to chemotherapy remains a major problem. More affordable chemotherapy agents such as (non-liposomal) doxorubicin, bleomycin, vincristine and etoposide may be currently administered in sub-Saharan Africa but they are associated with increased toxicity and lower efficacy for HIV-associated KS. Moreover, the infrastructure and expertise necessary to safely reconstitute and deliver intravenous chemotherapy are not available in many hospitals in Africa<sup><a href="#ref-30">30</a>,<a href="#ref-31">31</a></sup>. This is one of the main unmet needs in the management of KS in resource-poor countries and research and development as well as health policy efforts should therefore focus on the availability of oral, easily delivered, and inexpensive regimens in these regions.</p><p class="" id=d34136e444>A recent study conducted by the AIDS Clinical Trials Group and the AIDS Malignancy Consortium in Africa and Brazil demonstrated that oral etoposide is inferior to both intravenous paclitaxel and intravenous combination bleomycin and vincristine in advanced disease and that paclitaxel is somewhat better than combination bleomycin and vincristine<sup><a href="#ref-32">32</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d34136e454>Recent advances</h2><p class="" id=d34136e457>It must be noted that there is no accepted animal model for KS or KSHV infection for testing of drug therapies prior to clinical trials. Hence, in recent years, multiple targeted therapies for KS, especially oral medicines, have been directly routed to human trials. The most promising results have been achieved with pomalidomide, an orally available derivative of thalidomide that is less neurotoxic and has immune-modulatory, anti-angiogenic, and anti-proliferative activities. The effects against KS include modulation of tumour necrosis factor-alpha, interleukin-6, and vascular epithelial growth factor (VEGF) and enhancement of CD4<sup>+</sup> and CD8<sup>+</sup> T-cell co-stimulation. Notably, it is logically presumed with limited supporting <i>in vivo</i> data that the latter immunological factors are critical drivers in the development of KS<sup><a href="#ref-33">33</a></sup>. In a phase 2 study, 22 patients who received treatment achieved an overall response rate of 73%. Responses were rapid and occurred in HIV-positive and HIV-negative patients with advanced KS and in heavily pre-treated subjects<sup><a href="#ref-34">34</a></sup>. A trial conducted with a similar immunomodulatory agent, lenalidomide, had somewhat less favourable results with a response rate of 40% using the AIDS Clinical Trial Group (ACTG)-defined criteria and a 0% Physical Global Assessment (PGA) criteria response rate<sup><a href="#ref-35">35</a></sup> at week 48. Uldrick <i>et al</i>.<sup><a href="#ref-36">36</a></sup> published phase 2 trial results of the humanised monoclonal antibody bevacizumab, which targets VEGF-A, in HIV-associated KS. The overall response rate was only 31% despite the interesting role of VEGF-A in KS pathogenesis as a paracrine and autocrine growth factor for KS cells <i>in vitro</i><sup><a href="#ref-37">37</a></sup>. This points to the need for <i>in vivo</i> experimental data to support a definitive role for VEGF-A in the development of KS. Disappointing results have also been obtained with matrix metalloproteinase inhibitors<sup><a href="#ref-38">38</a></sup> and other angiogenesis inhibitors<sup><a href="#ref-39">39</a></sup>. Given that activation of platelet-derived growth factor (PDGF) and tyrosine kinase (TK) receptor c-kit has been demonstrated to have a role in KS pathogenesis both <i>in vitro</i> and <i>in vivo</i>, imatinib, a selective inhibitor of the TK Abl and c-kit, has been tested in HIV-KS with promising results<sup><a href="#ref-40">40</a></sup>. Similarly, KSHV-encoded proteins upregulate the mitogen-activated protein kinase (MAPK) pathway<sup><a href="#ref-41">41</a></sup>, and a clinical trial of the use of selumetinib, an inhibitor of this pathway, in HIV-KS is being completed. Rapamycin has been shown to be effective in transplantation-associated KS and has also been found to have activity in AIDS-KS but has significant drug–drug interactions with cART. Despite the pharmacokinetic interactions, that result in more than 200-fold differences in cumulative rapamycin doses between participants on protease inhibitor (PI)- and non-nucleoside reverse transcriptase inhibitor (NNRTI)-containing regimens, treatment was well tolerated<sup><a href="#ref-42">42</a></sup>.</p><p class="" id=d34136e526>The mechanisms behind the persistence or <i>de novo</i> development of HIV-associated KS in virally suppressed patients with a preserved CD4 T-cell count remain unclear. Anti-cancer immune response is closely linked to adaptive T-cell responses as part of a “cancer-immunity cycle”<sup><a href="#ref-43">43</a></sup>. This immune response is initiated with antigen priming of T lymphocytes: antigens are released by dying tumour cells and presented by dendritic cells via the major histocompatibility complex to the T-cell receptor. Primed T cells then traffic from the lymph node to the tumour site where they recognise and kill the cancer cells in the effector phase of adaptive immune response. Tumours have developed immune tolerogenic strategies that are delivered through complex mechanisms, including the modulation of multiple co-inhibitory and co-stimulatory pathways. Two immune checkpoints—cytotoxic T-lymphocyte–associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) pathways—respectively inhibit the priming and effector phase of cancer-specific immune response. They are therefore of great clinical interest in the development of new cancer immunotherapies.</p><p class="" id=d34136e536>In the context of chronic viral infections, including HIV and malignancy, the upregulation of PD-1 on cytotoxic T lymphocytes is a well-described mechanism of immune tolerance. In the HIV infection setting, chronic inflammation can lead to the exacerbation of immune exhaustion pathways with a subsequent decline in cancer immune surveillance and the development of a favourable oncogenic microenvironment<sup><a href="#ref-44">44</a></sup>. <i>In vitro</i> studies indicate that PD-L1 blockade reverses immune dysfunction of HIV-specific CD8 T cells with increased survival proliferation and cytokine production<sup><a href="#ref-45">45</a></sup>. Host <i>et al</i>. have also demonstrated that KSHV infection of primary human monocytes upregulates PD-L1 transcription and expression which highlight a new immune evasion strategy for KSHV<sup><a href="#ref-46">46</a></sup>.</p><p class="" id=d34136e557>In cART-refractory KS, our group has evaluated the potential for the PD-1 immune tolerance pathway as a mechanism underlying the pathogenesis and development of active KS in patients with well-controlled HIV stable on cART. Though limited by a small sample size of 10 patients, we confirmed PD-L1 upregulation with evidence of weak cytoplasmic PD-L1 expression in 50% of cases. Though differing from the intense membranous pattern of expression in epithelial malignancies that respond to PD-L1/PD-1 blockade <i>in vivo</i>, PD-L1–positive KS was associated with greater T-cell and macrophage infiltrate, hallmarks of an exhausted immune response to cancer<sup><a href="#ref-47">47</a></sup>.</p><p class="" id=d34136e568>Since our study, Galanina <i>et al</i>. reported on the efficacy and toxicity of immune checkpoint inhibitors (anti-PD-1 nivolumab and pembrolizumab) in nine patients with HIV-associated KS<sup><a href="#ref-48">48</a></sup>. The authors conducted a retrospective review of a heterogeneous group of patients: four patients had cutaneous disease only (T0), five patients had visceral disease (T1), seven out of nine patients had well-controlled HIV, and two had detectable plasma HIV RNA. Five patients had a good-risk immune status (I0) with a CD4 T-cell count above 200 cells/mL, and four patients had a CD4 count below the 200 cells/mL threshold<sup><a href="#ref-48">48</a></sup>. The patients were also heterogeneous in terms of prior treatment, having received from none up to four lines of systemic therapy prior to anti-PD-1 blockade, including liposomal anthracycline, paclitaxel, lenalidomide and bortezomib. One patient achieved complete remission, five out of nine patients achieved partial response, and three patients had stable disease. No one experienced KS progression and they were still on treatment at the time of reporting. Patients were evaluated for response every 4 weeks with KS response criteria defined by the AIDS Malignancy Consortium. The median progression-free survival has not been reached in the nine patients at a median follow-up of 5 months. No serious toxicity above grade 2 was observed in the study, and the most common side effects were fatigue, muscle aches and pruritus. Similar results were published in two cases of HIV-negative KS treated with nivolumab<sup><a href="#ref-49">49</a></sup>. The authors’ publication supports our provocative findings that PD-1 checkpoint blockade could have a therapeutic role in HIV-KS even in the presence of weak or no PD-L1 tumour expression in a similar way that good responses are observed in other virally induced tumours such as polyomavirus (MCPyV)-associated Merkel cell carcinoma<sup><a href="#ref-50">50</a></sup>. Nevertheless, the study is preliminary and does not lead to definitive conclusions as to the positioning of PD-1 therapy in KS. Longer prospective trials with the aim to better evaluate this treatment strategy are under way<sup><a href="#ref-51">51</a></sup>.</p><p class="" id=d34136e595>An additional benefit to the anti-tumour effect of anti-PD-1 therapy might be the potential role in HIV cure strategies. This immunotherapy is potentially able to reactivate latent HIV-1 and enhance HIV-specific antiviral response. The results on depleting latent HIV reservoirs so far are inconsistent<sup><a href="#ref-52">52</a>–<a href="#ref-54">54</a></sup> and limited but the effect of immune checkpoint inhibitors in this setting remains an area of interest where prospective studies are warranted. Especially because immune checkpoint blockade is associated with a risk of life-threatening autoimmune pathologies<sup><a href="#ref-55">55</a></sup>, studies of PD-1 blockade as a curative strategy in HIV should proceed with caution. Recent data are also highlighting the role of the PD-1 pathway in the priming of HIV T-cell responses; therefore, extra consideration should be taken in the timing of blocking this signalling pathway in order to avoid potential negative effects on the induction of <i>de novo</i> T-cell responses<sup><a href="#ref-56">56</a></sup>. Benefits may be limited to specific groups of patients with currently undefined predictors of response. Given the favourable toxicity profile of PD-1 blockade in the study by Galanina <i>et al</i>., the PD1 blockade described is more justified when the HIV research is combined with a cancer treatment strategy such as in KS.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d34136e622>Conclusions</h2><p class="" id=d34136e625>The introduction of cART has not resolved the challenge of HIV-associated KS. Unmet needs include access to liposomal anthracycline chemotherapy in sub-Saharan Africa for patients with advanced disease and the development of new treatment strategies for patients with cART-refractory KS who are currently intermittently treated long term with potentially toxic chemotherapy. The immune checkpoint inhibitor certainly represents a very interesting area to explore further given the parallel potential as an HIV cure strategy.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d34136e1 class=n-a></a><h2 class=main-title id=d34311>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d34136e632 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d34494>References</h2><div class="section ref-list"><a name=d34136e632 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d34136e639 class=n-a></a>Cook-Mozaffari P, Newton R, Beral V, <i> et al.</i>: The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. <i>Br J Cancer.</i> 1998; <b>78</b>(11): 1521–8. <a target=xrefwindow id=d34136e650 href="http://www.ncbi.nlm.nih.gov/pubmed/9836488">PubMed Abstract </a> | <a target=xrefwindow id=d34136e653 href="https://doi.org/10.1038/bjc.1998.717">Publisher Full Text </a> | <a target=xrefwindow id=d34136e657 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2063225">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730105025"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e666 class=n-a></a>Stefan DC: Patterns of distribution of childhood cancer in Africa. <i>J Trop Pediatr.</i> 2015; <b>61</b>(3): 165–73. <a target=xrefwindow id=d34136e674 href="http://www.ncbi.nlm.nih.gov/pubmed/25724211">PubMed Abstract </a> | <a target=xrefwindow id=d34136e677 href="https://doi.org/10.1093/tropej/fmv005">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730105025">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d34136e690 class=n-a></a>Ziegler JL, Katongole-Mbidde E: Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. <i>Int J Cancer.</i> 1996; <b>65</b>(2): 200–3. <a target=xrefwindow id=d34136e698 href="http://www.ncbi.nlm.nih.gov/pubmed/8567117">PubMed Abstract </a> | <a target="xrefwindow" id="d34136e701" href="https://doi.org/10.1002/(SICI)1097-0215(19960117)65:2<200::AID-IJC12&gt;3.0.CO;2-H">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d34136e710 class=n-a></a>WHO: Globocan 2018 - Home. Globocan 2018. 2018. NO: 11. </span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d34136e719 class=n-a></a>Gallafent JH, Buskin SE, de Turk PB, <i> et al.</i>: Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy. <i>J Clin Oncol.</i> 2005; <b>23</b>(6): 1253–60. <a target=xrefwindow id=d34136e730 href="http://www.ncbi.nlm.nih.gov/pubmed/15718323">PubMed Abstract </a> | <a target=xrefwindow id=d34136e733 href="https://doi.org/10.1200/JCO.2005.04.156">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d34136e743 class=n-a></a>Holkova B, Takeshita K, Cheng DM, <i> et al.</i>: Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy. <i>J Clin Oncol.</i> 2001; <b>19</b>(18): 3848–51. <a target=xrefwindow id=d34136e754 href="http://www.ncbi.nlm.nih.gov/pubmed/11559722">PubMed Abstract </a> | <a target=xrefwindow id=d34136e757 href="https://doi.org/10.1200/JCO.2001.19.18.3848">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d34136e766 class=n-a></a>Tam HK, Zhang ZF, Jacobson LP, <i> et al.</i>: Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. <i>Int J Cancer.</i> 2002; <b>98</b>(6): 916–22. <a target=xrefwindow id=d34136e777 href="http://www.ncbi.nlm.nih.gov/pubmed/11948473">PubMed Abstract </a> | <a target=xrefwindow id=d34136e780 href="https://doi.org/10.1002/ijc.10274">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d34136e789 class=n-a></a>Hleyhel M, Belot A, Bouvier AM, <i> et al.</i>: Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort. <i>Clin Infect Dis.</i> 2013; <b>57</b>(11): 1638–47. <a target=xrefwindow id=d34136e800 href="http://www.ncbi.nlm.nih.gov/pubmed/23899679">PubMed Abstract </a> | <a target=xrefwindow id=d34136e803 href="https://doi.org/10.1093/cid/cit497">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d34136e812 class=n-a></a>Gill J, Bourboulia D, Wilkinson J, <i> et al.</i>: Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma. <i>J Acquir Immune Defic Syndr.</i> 2002; <b>31</b>(4): 384–90. <a target=xrefwindow id=d34136e823 href="http://www.ncbi.nlm.nih.gov/pubmed/12447008">PubMed Abstract </a> | <a target=xrefwindow id=d34136e826 href="https://doi.org/10.1097/00126334-200212010-00003">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d34136e835 class=n-a></a>Paparizos VA, Kyriakis KP, Papastamopoulos V, <i> et al.</i>: Response of AIDS-Associated Kaposi Sarcoma to Highly Active Antiretroviral Therapy Alone. <i>J Acquir Immune Defic Syndr.</i> 2002; <b>30</b>(2): 257–8. <a target=xrefwindow id=d34136e846 href="http://www.ncbi.nlm.nih.gov/pubmed/12045689">PubMed Abstract </a> | <a target=xrefwindow id=d34136e849 href="https://doi.org/10.1097/00042560-200206010-00015">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d34136e858 class=n-a></a>Mosam A, Shaik F, Uldrick TS, <i> et al.</i>: A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa. <i>J Acquir Immune Defic Syndr.</i> 2012; <b>60</b>(2): 150–7. <a target=xrefwindow id=d34136e869 href="http://www.ncbi.nlm.nih.gov/pubmed/22395672">PubMed Abstract </a> | <a target=xrefwindow id=d34136e872 href="https://doi.org/10.1097/QAI.0b013e318251aedd">Publisher Full Text </a> | <a target=xrefwindow id=d34136e876 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3360837">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d34136e886 class=n-a></a>Martín-Carbonero L, Barrios A, Saballs P, <i> et al.</i>: Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma. <i>AIDS.</i> 2004; <b>18</b>(12): 1737–40. <a target=xrefwindow id=d34136e897 href="http://www.ncbi.nlm.nih.gov/pubmed/15280789">PubMed Abstract </a> | <a target=xrefwindow id=d34136e900 href="https://doi.org/10.1097/01.aids.0000131385.60974.b9">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d34136e909 class=n-a></a>Feller L, Anagnostopoulos C, Wood NH, <i> et al.</i>: Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report. <i>J Periodontol.</i> 2008; <b>79</b>(2): 362–8. <a target=xrefwindow id=d34136e920 href="http://www.ncbi.nlm.nih.gov/pubmed/18251652">PubMed Abstract </a> | <a target=xrefwindow id=d34136e923 href="https://doi.org/10.1902/jop.2008.070225">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d34136e932 class=n-a></a>Pal J, Shrivastav A, Pathak HS, <i> et al.</i>: Immune reconstitution inflammatory syndrome associated with acquired immunodeficiency syndrome-related gastrointestinal limited Kaposi's sarcoma presenting as acute intestinal obstruction: a case report. <i>J Med Case Rep.</i> 2011; <b>5</b>: 327. <a target=xrefwindow id=d34136e943 href="http://www.ncbi.nlm.nih.gov/pubmed/21791047">PubMed Abstract </a> | <a target=xrefwindow id=d34136e946 href="https://doi.org/10.1186/1752-1947-5-327">Publisher Full Text </a> | <a target=xrefwindow id=d34136e950 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3159110">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d34136e959 class=n-a></a>Leidner RS, Aboulafia DM: Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. <i>AIDS Patient Care STDS.</i> 2005; <b>19</b>(10): 635–44. <a target=xrefwindow id=d34136e967 href="http://www.ncbi.nlm.nih.gov/pubmed/16232048">PubMed Abstract </a> | <a target=xrefwindow id=d34136e970 href="https://doi.org/10.1089/apc.2005.19.635">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d34136e979 class=n-a></a>Read PJ, Lucas S, Morris S, <i> et al.</i>: Immune reconstitution inflammatory syndrome Kaposi sarcoma in the liver manifesting as acute obstructive hepatitis: another potential role for montelukast? <i>Int J STD AIDS.</i> 2013; <b>24</b>(2): 156–8. <a target=xrefwindow id=d34136e990 href="http://www.ncbi.nlm.nih.gov/pubmed/24400347">PubMed Abstract </a> | <a target=xrefwindow id=d34136e993 href="https://doi.org/10.1177/0956462412472819">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725828169"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1002 class=n-a></a>Northfelt DW, Dezube BJ, Thommes JA, <i> et al.</i>: Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. <i>J Clin Oncol.</i> 1998; <b>16</b>(7): 2445–51. <a target=xrefwindow id=d34136e1013 href="http://www.ncbi.nlm.nih.gov/pubmed/9667262">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1016 href="https://doi.org/10.1200/JCO.1998.16.7.2445">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725828169">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735915916"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1030 class=n-a></a>Stewart S, Jablonowski H, Goebel FD, <i> et al.</i>: Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group. <i>J Clin Oncol.</i> 1998; <b>16</b>(2): 683–91. <a target=xrefwindow id=d34136e1041 href="http://www.ncbi.nlm.nih.gov/pubmed/9469358">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1044 href="https://doi.org/10.1200/JCO.1998.16.2.683">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735915916">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d34136e1057 class=n-a></a>Lichterfeld M, Qurishi N, Hoffmann C, <i> et al.</i>: Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery. <i>Infection.</i> 2005; <b>33</b>(3): 140–7. <a target=xrefwindow id=d34136e1068 href="http://www.ncbi.nlm.nih.gov/pubmed/15940415">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1071 href="https://doi.org/10.1007/s15010-005-4099-z">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d34136e1080 class=n-a></a>Bower M, Weir J, Francis N, <i> et al.</i>: The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma. <i>AIDS.</i> 2009; <b>23</b>(13): 1701–6. <a target=xrefwindow id=d34136e1091 href="http://www.ncbi.nlm.nih.gov/pubmed/19550283">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1094 href="https://doi.org/10.1097/QAD.0b013e32832d080d">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d34136e1103 class=n-a></a>Bower M, Palfreeman A, Alfa-Wali M, <i> et al.</i>: British HIV Association guidelines for HIV-associated malignancies 2014. <i>HIV Med.</i> 2014; <b>15 Suppl 2</b>: 1–92. <a target=xrefwindow id=d34136e1114 href="http://www.ncbi.nlm.nih.gov/pubmed/24528810">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1117 href="https://doi.org/10.1111/hiv.12136">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d34136e1126 class=n-a></a>Bower M, Dalla Pria A, Coyle C, <i> et al.</i>: Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma. <i>J Clin Oncol.</i> 2014; <b>32</b>(5): 409–14. <a target=xrefwindow id=d34136e1137 href="http://www.ncbi.nlm.nih.gov/pubmed/24378415">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1140 href="https://doi.org/10.1200/JCO.2013.51.6757">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d34136e1149 class=n-a></a>Stebbing J, Powles T, Bower M: AIDS-associated Kaposi's sarcoma associated with a low viral load and a high CD4 cell count. <i>AIDS.</i> 2008; <b>22</b>(4): 551–2. <a target=xrefwindow id=d34136e1157 href="http://www.ncbi.nlm.nih.gov/pubmed/18301078">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1160 href="https://doi.org/10.1097/QAD.0b013e3282f4de5d">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718012314"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1170 class=n-a></a>Daly ML, Fogo A, McDonald C, <i> et al.</i>: Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm<sup>3</sup> at presentation. <i>Clin Exp Dermatol.</i> 2014; <b>39</b>(1): 7–12. <a target=xrefwindow id=d34136e1184 href="http://www.ncbi.nlm.nih.gov/pubmed/23691969">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1188 href="https://doi.org/10.1111/ced.12163">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718012314">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d34136e1201 class=n-a></a>Mocroft A, Furrer HJ, Miro JM, <i> et al.</i>: The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. <i>Clin Infect Dis.</i> 2013; <b>57</b>(7): 1038–47. <a target=xrefwindow id=d34136e1212 href="http://www.ncbi.nlm.nih.gov/pubmed/23921881">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1215 href="https://doi.org/10.1093/cid/cit423">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d34136e1224 class=n-a></a>Unemori P, Leslie KS, Hunt PW, <i> et al.</i>: Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection. <i>AIDS.</i> 2013; <b>27</b>(11): 1735–42. <a target=xrefwindow id=d34136e1235 href="http://www.ncbi.nlm.nih.gov/pubmed/23435301">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1238 href="https://doi.org/10.1097/QAD.0b013e3283601144">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1242 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4063793">Free Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d34136e1251 class=n-a></a>Mani D, Neil N, Israel R, <i> et al.</i>: A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm<sup>3</sup>. <i>J Int Assoc Physicians AIDS Care (Chic).</i> 2009; <b>8</b>(5): 279–85. <a target=xrefwindow id=d34136e1265 href="http://www.ncbi.nlm.nih.gov/pubmed/19721098">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1269 href="https://doi.org/10.1177/1545109709341852">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d34136e1278 class=n-a></a>Rafiyath SM, Rasul M, Lee B, <i> et al.</i>: Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis. <i>Exp Hematol Oncol.</i> 2012; <b>1</b>(1): 10. <a target=xrefwindow id=d34136e1289 href="http://www.ncbi.nlm.nih.gov/pubmed/23210520">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1292 href="https://doi.org/10.1186/2162-3619-1-10">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1296 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3514106">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1108555"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1305 class=n-a></a>Windebank AJ, Grisold W: Chemotherapy-induced neuropathy. <i>J Peripher Nerv Syst.</i> 2008; <b>13</b>(1): 27–46. <a target=xrefwindow id=d34136e1313 href="http://www.ncbi.nlm.nih.gov/pubmed/18346229">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1316 href="https://doi.org/10.1111/j.1529-8027.2008.00156.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1108555">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733166783"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1330 class=n-a></a>Chalya PL, Mbunda F, Rambau PF, <i> et al.</i>: Kaposi's sarcoma: a 10-year experience with 248 patients at a single tertiary care hospital in Tanzania. <i>BMC Res Notes.</i> 2015; <b>8</b>: 440. <a target=xrefwindow id=d34136e1341 href="http://www.ncbi.nlm.nih.gov/pubmed/26374100">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1344 href="https://doi.org/10.1186/s13104-015-1348-9">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1348 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5439227">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733166783">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726720935"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1361 class=n-a></a>Chinula L, Moses A, Gopal S: HIV-associated malignancies in sub-Saharan Africa: Progress, challenges, and opportunities. <i>Curr Opin HIV AIDS.</i> 2017; <b>12</b>(1): 89–95. <a target=xrefwindow id=d34136e1369 href="http://www.ncbi.nlm.nih.gov/pubmed/27607593">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1372 href="https://doi.org/10.1097/COH.0000000000000329">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1375 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5241291">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726720935">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d34136e1388 class=n-a></a>NIH: AIDS-Kaposi’s Sarcoma Study Changed Due to Drug Underperformance Oral Etoposide Plus Antiretroviral Therapy Study Arm Discontinued. 2016. <a target=xrefwindow id=d34136e1390 href="https://www.niaid.nih.gov/news-events/aids-kaposi%E2%80%99s-sarcoma-study-changed-due-drug-underperformance">Reference Source</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735915864"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1399 class=n-a></a>Bolanos R, Martinez-Maza O, Zhang ZF, <i> et al.</i>: Decreased levels of the serum inflammatory biomarkers, sGP130, IL-6, sCRP and BAFF, are associated with increased likelihood of AIDS related Kaposi’s sarcoma in men who have sex with men. <i>Cancer Res Front.</i> 2018; <b>4</b>(1): 45–59. <a target=xrefwindow id=d34136e1410 href="https://doi.org/10.17980/2018.45">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735915864">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726994250"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1423 class=n-a></a>Polizzotto MN, Uldrick TS, Wyvill KM, <i> et al.</i>: Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study. <i>J Clin Oncol.</i> 2016; <b>34</b>(34): 4125–31. <a target=xrefwindow id=d34136e1434 href="http://www.ncbi.nlm.nih.gov/pubmed/27863194">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1437 href="https://doi.org/10.1200/JCO.2016.69.3812">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1441 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5477825">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726994250">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735915890"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1454 class=n-a></a>Pourcher V, Desnoyer A, Assoumou L, <i> et al.</i>: Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial. <i>AIDS Res Hum Retroviruses.</i> 2017; <b>33</b>(1): 1–10. <a target=xrefwindow id=d34136e1465 href="http://www.ncbi.nlm.nih.gov/pubmed/27405442">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1468 href="https://doi.org/10.1089/aid.2016.0069">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735915890">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d34136e1482 class=n-a></a>Uldrick TS, Wyvill KM, Kumar P, <i> et al.</i>: Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy. <i>J Clin Oncol.</i> 2012; <b>30</b>(13): 1476–83. <a target=xrefwindow id=d34136e1493 href="http://www.ncbi.nlm.nih.gov/pubmed/22430271">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1496 href="https://doi.org/10.1200/JCO.2011.39.6853">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1500 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3383119">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d34136e1509 class=n-a></a>Masood R, Cai J, Zheng T, <i> et al.</i>: Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. <i>Proc Natl Acad Sci U S A.</i> 1997; <b>94</b>(3): 979–84. <a target=xrefwindow id=d34136e1520 href="http://www.ncbi.nlm.nih.gov/pubmed/9023368">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1523 href="https://doi.org/10.1073/pnas.94.3.979">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1527 href="http://www.ncbi.nlm.nih.gov/pmc/articles/19625">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d34136e1536 class=n-a></a>Dezube BJ, Krown SE, Lee JY, <i> et al.</i>: Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study. <i>J Clin Oncol.</i> 2006; <b>24</b>(9): 1389–94. <a target=xrefwindow id=d34136e1547 href="http://www.ncbi.nlm.nih.gov/pubmed/16549833">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1550 href="https://doi.org/10.1200/JCO.2005.04.2614">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d34136e1559 class=n-a></a>Noy A, Scadden DT, Lee J, <i> et al.</i>: Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team. <i>J Clin Oncol.</i> 2005; <b>23</b>(5): 990–8. <a target=xrefwindow id=d34136e1570 href="http://www.ncbi.nlm.nih.gov/pubmed/15598977">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1573 href="https://doi.org/10.1200/JCO.2005.11.043">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d34136e1582 class=n-a></a>Koon HB, Bubley GJ, Pantanowitz L, <i> et al.</i>: Imatinib-induced regression of AIDS-related Kaposi's sarcoma. <i>J Clin Oncol.</i> 2005; <b>23</b>(5): 982–9. <a target=xrefwindow id=d34136e1593 href="http://www.ncbi.nlm.nih.gov/pubmed/15572730">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1596 href="https://doi.org/10.1200/JCO.2005.06.079">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d34136e1605 class=n-a></a>Vart RJ, Nikitenko LL, Lagos D, <i> et al.</i>: Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. <i>Cancer Res.</i> 2007; <b>67</b>(9): 4042–51. <a target=xrefwindow id=d34136e1616 href="http://www.ncbi.nlm.nih.gov/pubmed/17483315">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1619 href="https://doi.org/10.1158/0008-5472.CAN-06-3321">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/14263020"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1629 class=n-a></a>Krown SE, Roy D, Lee JY, Dezube BJ, <i> et al.</i>: Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study. <i>J Acquir Immune Defic Syndr.</i> 2012; <b>59</b>(5): 447–54. <a target=xrefwindow id=d34136e1640 href="http://www.ncbi.nlm.nih.gov/pubmed/22067664">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1643 href="https://doi.org/10.1097/QAI.0b013e31823e7884">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1647 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3302934">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/14263020">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d34136e1660 class=n-a></a>Chen DS, Mellman I: Oncology meets immunology: the cancer-immunity cycle. <i>Immunity.</i> 2013; <b>39</b>(1): 1–10. <a target=xrefwindow id=d34136e1668 href="http://www.ncbi.nlm.nih.gov/pubmed/23890059">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1671 href="https://doi.org/10.1016/j.immuni.2013.07.012">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d34136e1680 class=n-a></a>Shankar P, Russo M, Harnisch B, <i> et al.</i>: Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. <i>Blood.</i> 2000; <b>96</b>(9): 3094–101. <a target=xrefwindow id=d34136e1691 href="http://www.ncbi.nlm.nih.gov/pubmed/11049989">PubMed Abstract </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d34136e1700 class=n-a></a>Trautmann L, Janbazian L, Chomont N, <i> et al.</i>: Upregulation of PD-1 expression on HIV-specific CD8<sup>+</sup> T cells leads to reversible immune dysfunction. <i>Nat Med.</i> 2006; <b>12</b>(10): 1198–202. <a target=xrefwindow id=d34136e1714 href="http://www.ncbi.nlm.nih.gov/pubmed/16917489">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1718 href="https://doi.org/10.1038/nm1482">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731966587"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1727 class=n-a></a>Host KM, Jacobs SR, West JA, <i> et al.</i>: Kaposi's Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes. <i>mBio.</i> 2017; <b>8</b>(5): pii: e00917-17. <a target=xrefwindow id=d34136e1738 href="http://www.ncbi.nlm.nih.gov/pubmed/29018115">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1741 href="https://doi.org/10.1128/mBio.00917-17">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1745 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5635685">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731966587">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d34136e1758 class=n-a></a>Mletzko S, Pinato DJ, Robey RC, <i> et al.</i>: Programmed death ligand 1 (PD-L1) expression influences the immune-tolerogenic microenvironment in antiretroviral therapy-refractory Kaposi's sarcoma: A pilot study. <i>Oncoimmunology.</i> 2017; <b>6</b>(8): e1304337. <a target=xrefwindow id=d34136e1769 href="http://www.ncbi.nlm.nih.gov/pubmed/28919987">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1772 href="https://doi.org/10.1080/2162402X.2017.1304337">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1776 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5593697">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733983733"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1786 class=n-a></a>Galanina N, Goodman AM, Cohen PR, <i> et al.</i>: Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint Blockade. <i>Cancer Immunol Res.</i> 2018; <b>6</b>(10): 1129–35. <a target=xrefwindow id=d34136e1797 href="http://www.ncbi.nlm.nih.gov/pubmed/30194084">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1800 href="https://doi.org/10.1158/2326-6066.CIR-18-0121">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1804 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6248326">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733983733">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732453309"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1817 class=n-a></a>Delyon J, Bizot A, Battistella M, <i> et al.</i>: PD-1 blockade with nivolumab in endemic Kaposi sarcoma. <i>Ann Oncol.</i> 2018; <b>29</b>(4): 1067–9. <a target=xrefwindow id=d34136e1828 href="http://www.ncbi.nlm.nih.gov/pubmed/29324995">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1831 href="https://doi.org/10.1093/annonc/mdy006">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732453309">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726295412"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1844 class=n-a></a>Nghiem PT, Bhatia S, Lipson EJ, <i> et al.</i>: PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. <i>N Engl J Med.</i> 2016; <b>374</b>(26): 2542–52. <a target=xrefwindow id=d34136e1855 href="http://www.ncbi.nlm.nih.gov/pubmed/27093365">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1858 href="https://doi.org/10.1056/NEJMoa1603702">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1862 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4927341">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726295412">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d34136e1875 class=n-a></a>Uldrick TS: Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms. <a target=xrefwindow id=d34136e1877 href="https://clinicaltrials.gov/ct2/show/NCT02595866">Reference Source</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732229998"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1886 class=n-a></a>Guihot A, Marcelin AG, Massiani MA, <i> et al.</i>: Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer. <i>Ann Oncol.</i> 2018; <b>29</b>(2): 517–8. <a target=xrefwindow id=d34136e1897 href="http://www.ncbi.nlm.nih.gov/pubmed/29206889">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1900 href="https://doi.org/10.1093/annonc/mdx696">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732229998">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735915892"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1913 class=n-a></a>Le Garff G, Samri A, Lambert-Niclot S, <i> et al.</i>: Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab. <i>AIDS.</i> 2017; <b>31</b>(7): 1048–51. <a target=xrefwindow id=d34136e1924 href="http://www.ncbi.nlm.nih.gov/pubmed/28350581">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1927 href="https://doi.org/10.1097/QAD.0000000000001429">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735915892">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d34136e1941 class=n-a></a>Scully EP, Rutishauser RL, Simoneau CR, <i> et al.</i>: Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection. <i>Ann Oncol.</i> 2018; <b>29</b>(10): 2141–2. <a target=xrefwindow id=d34136e1952 href="http://www.ncbi.nlm.nih.gov/pubmed/30032204">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1955 href="https://doi.org/10.1093/annonc/mdy259">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1959 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6225895">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725788239"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1968 class=n-a></a>Naidoo J, Page DB, Li BT, <i> et al.</i>: Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. <i>Ann Oncol.</i> 2015; <b>26</b>(12): 2375–91. <a target=xrefwindow id=d34136e1979 href="http://www.ncbi.nlm.nih.gov/pubmed/26371282">PubMed Abstract </a> | <a target=xrefwindow id=d34136e1982 href="https://doi.org/10.1093/annonc/mdv383">Publisher Full Text </a> | <a target=xrefwindow id=d34136e1986 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6267867">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725788239">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734627112"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d34136e1999 class=n-a></a>Garcia-Bates TM, Palma ML, Shen C, <i> et al.</i>: Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions. <i>J Virol.</i> 2019; <b>93</b>(5): pii: e02035-18 <a target=xrefwindow id=d34136e2010 href="http://www.ncbi.nlm.nih.gov/pubmed/30541848">PubMed Abstract </a> | <a target=xrefwindow id=d34136e2013 href="https://doi.org/10.1128/JVI.02035-18">Publisher Full Text </a> | <a target=xrefwindow id=d34136e2017 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6384070">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734627112">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 26 Jun 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-970/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-970/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Imperial College London, London, UK<br/> <sup>2</sup> Chelsea and Westminster Hospital, London, UK<br/> <p> <div class=margin-bottom> Alessia Dalla Pria <br/> <span>Roles: </span> Conceptualization, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> David J. Pinato <br/> <span>Roles: </span> Conceptualization, Data Curation, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Margherita Bracchi <br/> <span>Roles: </span> Conceptualization, Data Curation, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Mark Bower <br/> <span>Roles: </span> Conceptualization, Data Curation, Investigation, Methodology, Project Administration, Resources, Software, Supervision, Validation, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-970/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 26 Jun 2019, 8:970 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.17401.1">https://doi.org/10.12688/f1000research.17401.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2019 Dalla Pria A <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=19029 data-id=17401 data-downloads="" data-views="" data-scholar="10.12688/f1000research.17401.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-970/v1/pdf?article_uuid=c774e904-58dd-43de-8141-fb24c9942fb2" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.17401.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Dalla Pria A, Pinato DJ, Bracchi M and Bower M. Recent advances in HIV-associated Kaposi sarcoma [version 1; peer review: 2 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):970 (<a href="https://doi.org/10.12688/f1000research.17401.1" target=_blank>https://doi.org/10.12688/f1000research.17401.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=17401 id=mobile-track-article-signin-17401 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/17401?target=/articles/8-970/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=19029 /> <input name=articleId type=hidden value=17401 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Robert Yarchoan</strong>, HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> Robert Yarchoan is a co-inventor on US Patent 10,001,483 entitled "Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers". The patent application for this was filed in part based on the results of NCI protocol 12-C-0047, entitled "A Phase I/II Study of the Safety, Pharmacokinetics and Efficacy of Pomalidomide (CC-4047) in the Treatment of Kaposi Sarcoma in Individuals with or without HIV". It is his understanding that foreign patents have also been filed for this invention. This invention was made as a full-time employee of the US government under 45 Code of Federal Regulations Part 7. His spouse, who is also a US Government employee, has a patent on KSHV viral IL-6. All rights, title, and interest to these patents have been or should by law be assigned to the U.S. Department of Health and Human Services. The government conveys a portion of the royalties it receives to its employee-inventors under the Federal Technology Transfer Act of 1986 (P.L. 99-502).   Robert Yarchoan's research is funded in part by Cooperative Research and Development Agreements (CRADAs) between Celgene Corporation and the National Cancer Institute. As part of this agreement, Celgene has provided drugs for clinical trials. Bevacizumab for his trial of bevacizumab alone and with liposomal doxorubicin was provided to the NCI under a CRADA with Genetech, and drugs for his trial of pembrolizumab is provided to the NCI by a CRADA with Merck & Co. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Charles R Rinaldo</strong>, Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 26 Jun 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/8-970/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/8-970/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=52339-49662></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=35937-49663></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-970/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>26 Jun 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Robert Yarchoan</strong>, HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> Robert Yarchoan is a co-inventor on US Patent 10,001,483 entitled "Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers". The patent application for this was filed in part based on the results of NCI protocol 12-C-0047, entitled "A Phase I/II Study of the Safety, Pharmacokinetics and Efficacy of Pomalidomide (CC-4047) in the Treatment of Kaposi Sarcoma in Individuals with or without HIV". It is his understanding that foreign patents have also been filed for this invention. This invention was made as a full-time employee of the US government under 45 Code of Federal Regulations Part 7. His spouse, who is also a US Government employee, has a patent on KSHV viral IL-6. All rights, title, and interest to these patents have been or should by law be assigned to the U.S. Department of Health and Human Services. The government conveys a portion of the royalties it receives to its employee-inventors under the Federal Technology Transfer Act of 1986 (P.L. 99-502).   Robert Yarchoan's research is funded in part by Cooperative Research and Development Agreements (CRADAs) between Celgene Corporation and the National Cancer Institute. As part of this agreement, Celgene has provided drugs for clinical trials. Bevacizumab for his trial of bevacizumab alone and with liposomal doxorubicin was provided to the NCI under a CRADA with Genetech, and drugs for his trial of pembrolizumab is provided to the NCI by a CRADA with Merck & Co. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Charles R Rinaldo</strong>, Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-970/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-970/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in HIV-associated Kaposi...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-970/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-970/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-970/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Dalla Pria A et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-970/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-970",
            templates : {
                twitter : "Recent advances in HIV-associated Kaposi sarcoma. Dalla Pria A et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-970/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in HIV-associated Kaposi sarcoma", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in HIV-associated Kaposi sarcoma", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/17401/19029")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "19029");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "49662": 0,
                           "49663": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "f19684d3-8e1b-4f8c-8038-fe3ca99e0eee";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-970.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-970.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-970.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-970.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-970.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>